# Evaluate Analgesic Efficacy of Fast Release Aspirin

> **NCT01117636** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 514 (actual)

## Conditions studied

- Drugs, Investigational

## Interventions

- **DRUG:** Acetylsalicylic acid (Fast release Aspirin, BAY1019036)
- **DRUG:** Acetylsalicylic Acid (Aspirin, BAYE4465)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01117636
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-28
- **Primary completion:** 2010-07-07
- **Final completion:** 2010-07-07
- **Target enrollment:** 514 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117636, "Evaluate Analgesic Efficacy of Fast Release Aspirin". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01117636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*